Enzymes, the core catalysts in life, drive critical biological processes ranging from metabolic regulation to energy ...

The convergence of AI and drug delivery is opening new frontiers in precision medicine. AI-powered predictive modeling is being used to simulate drug interactions, optimize nanoparticle design, and ...

“The use of biocatalysis for greener, more sustainable drug development and manufacturing is growing. Our works shows that by replacing traditional chemical methods with enzyme-driven reactions, we ...

Using computational tools and virtual screening, researchers at the Center for Redox Processes in Biomedicine (Redoxoma) have identified new inhibitors of the enzyme human 15-lipoxygenase-2 (h15-LOX-2 ...

Lexicon's stock rose 60% after securing a potential $1 billion deal with Novo Nordisk for preclinical obesity drug LX9851.

Lexicon's LX9851 targets ACSL5, a liver enzyme involved in fat metabolism that helps moderate fat accumulation and slow down ...